![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 23
Zeitschriftenartikel
Stecher, S. S.; Stemmler, H. J.; Tischer, J.; Bergwelt-Baildon, M. von; Liebregts, T. und Fraccaroli, A.
(2021):
Der knochenmarktransplantierte Patient auf der Intensivstation.
In: Medizinische Klinik-Intensivmedizin und Notfallmedizin, Bd. 116, Nr. 2: S. 111-120
Nasso, D.; Labopin, M.; Ruggeri, A.; Ciceri, F.; Lint, M. T. van; Arcese, W.; Tischer, J.; Blaise, D.; Ehninger, G.; Koc, Y.; Santarone, S.; Bruno, B.; Huang, X.-J.; Savani, B. N.; Mohty, M. und Nagler, A.
(2017):
Impact of Conditioning Regimen on Outcomes of T-Replete Haplo-Identical Transplantation for Patients Over 45 Years-Old with AML: A Study On Behalf Of the Acute Leukemia Working Party of the EBMT.
In: Haematologica, Bd. 102: S. 132
Fraccaroli, A.; Prevalsek, D.; Häbe, S.; Schulz, C.; Roiss, M.; Bücklein, V.; Lippl, S.; Herold, T.; Stemmler, H.-J.; Spiekermann, K.; Ledderose, G.; Hiddemann, W. und Tischer, J.
(2017):
HLA haploidentical allografting using post transplantation cyclophosphamide in high-risk and advanced MDS and AML patients aged over 50 years: feasibility and outcome.
In: Oncology Research and Treatment, Bd. 40: S. 102
Wagner, B.; Albert, M. H.; Tischer, J.; Ostermann, H. und Wittmann, G.
(2017):
Effect of collection device on product quality in allogeneic and autologous PBSCT.
In: Transfusion Medicine and Hemotherapy, Bd. 44: S. 77
Malard, F.; Labopin, M.; Stuhler, G.; Bittenbring, J.; Ganser, A.; Tischer, J.; Michallet, M.; Kroeger, N.; Schmid, C.; Huynh, A.; Hallek, M.; Savani, B.; Mohty, M. und Nagler, A.
(2016):
Sequential intensified conditioning regimen allogeneic hematopoietic stem cell transplantation in adult patients with high-risk AML in complete remission: a survey from the ALWP of the EBMT.
In: Bone Marrow Transplantation, Bd. 51:
S11-S11
Christopeit, M.; Tischer, J.; Schetelig, J.; Bornhäuser, M.; Uharek, L.; Wolff, D.; Holler, E.; Pfrepper, C.; Behre, G.; Niederwieser, D.; Kroeger, N.; Kobbe, G.; Weber, T.; Müller, L. P.; Rösler, W.; Klein, S.; Hausmann, A.; Beelen, D. W.; Bethge, W. und Schmid, C.
(2016):
Haploidentical second allogeneic hematopoietic stem cell transplantation for the treatment of acute leukemia relapse after first allo-HSCT: An updated retrospective registry analysis of 69 pts on behalf of the German Cooperative Transplant Group.
In: Oncology Research and Treatment, Bd. 39: S. 168
Prevalsek, D.; Fritsch, S.; Hubmann, M.; Zoellner, A.-K.; Köhnke, T.; Engel, N.; Bücklein, V. L.; Schulz, C.; Mumm, F.; Berking, S.; Ledderose, G.; Stemmler, H.-J.; Spiekermann, K.; Hiddemann, W.; Hausmann, A. und Tischer, J.
(2016):
Results of sequential therapy in the setting of unmanipulated HLA-haploidentical transplantation utilizing post-transplantation high-dose cyclophosphamide in the treatment of high-risk AML and MDS.
In: Oncology Research and Treatment, Bd. 39: S. 77-78
Gorkom, G. van; Gelder, M. van; Ziagkos, D.; Koster, L.; Koc, Y.; Lint, M. van; Ciceri, F.; Selleslag, D.; Blaise, D.; Foa, R.; Beelen, D.; Corradini, P.; Moreno, C.; Carlson, K.; Solano, C.; Müller, L. P.; Castagna, L.; Tischer, J.; Hilgendorf, I.; Hallek, M.; Bittenbring, J.; Theobald, M.; Schetelig, J. und Kroeger, N.
(2016):
Outcomes of mismatched related allogeneic stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT.
In: Bone Marrow Transplantation, Bd. 51:
S293-S294
Sirin, M.; Moshous, D.; Hoenig, M.; Schuetz, C.; Neven, B.; Cavazzana, M.; Fischer, A.; Blanche, S.; Tischer, J.; Schulz, A. und Albert, M. H.
(2016):
T-cell replete haploidentical hematopoietic stem cell transplantation (HSCT) as salvage therapy for acute rejection/graft failure in pediatric patients with nonmalignant disorders.
In: Bone Marrow Transplantation, Bd. 51:
S458-S459
Santoro, N.; Labopin, M.; Ruggeri, A.; Bacigalupo, A.; Ciceri, F.; Guelbas, Z.; Koc, Y.; Arcese, W.; Wu, D.; Huang, H.; Afanasyev, B.; Tischer, J.; Ozdogu, H.; Giebel, S.; Mothy, M. und Nagler, A.
(2016):
Unmanipulated haploidentical stem cell transplantation in adults with Acute Lymphoblastic Leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.
In: Bone Marrow Transplantation, Bd. 51:
S2-S2
Ringden, O.; Labopin, M.; Schmid, C.; Sadeghi, B.; Polge, E.; Tischer, J.; Ganser, A.; Michallet, M.; Kanz, L.; Schwerdtfeger, R.; Nagler, A. und Mohty, M.
(2016):
Sequential chemotherapy followed by reduced intensity conditioning and allogeneic hematopoietic stem cell transplantation in adult patients with relapse or refractory acute myeloid leukemia (AML): a survey from the Acute Leukemia Working Party of EBMT.
In: Bone Marrow Transplantation, Bd. 51:
S476-S477
Prevalsek, D.; Fritsch, S.; Hubmann, M.; Zoellner, A.-K.; Koehnke, T.; Buecklein, V. L.; Mumm, F.; Haebe, S.; Witkowski, L.; Ledderose, G.; Stemmler, H.-J.; Spiekermann, K.; Hiddemann, W.; Hausmann, A. und Tischer, J.
(2016):
Sequential therapy in the setting of HLA-haploidentical transplantation utilizing T-cell-replete grafts and post-transplantation high-dose cyclophosphamide in the treatment of relapsed and refractory acute myeloid leukemia and myelodysplastic syndrome.
In: Bone Marrow Transplantation, Bd. 51:
S29-S30
Lorentino, F.; Ciceri, F.; Labopin, M.; Ruggeri, A.; Guelbas, Z.; Koc, Y.; Arcese, W.; Bruno, B.; Tischer, J.; Lint, M. T. van; Blaise, D.; Messina, G.; Bornhaeuser, M.; Fleischhauer, K.; Beelen, D. W.; Nagler, A. und Mohty, M.
(2016):
HLA disparities on unshared haplotype influence outcomes of unmanipulated haploidentical hematopoietic stem cell transplantation (HaploSCT): A Study from the Acute Leukemia Working Party of European Society for Blood and Marrow Transplantation (EBMT).
In: Bone Marrow Transplantation, Bd. 51:
S28-S29
Inngjerdingen, M.; Rabe, A.; Deen, D.; Stankova, Z.; Hirn, A.; Tischer, J.; Schmid, C. und Schmetzer, H.
(2016):
Immunemodulation of AML-blasts with clinically approved response modifiers improves antileukemic T-cell reactivity ex vivo and leads to blast-reduction in vivo (rat-Modell).
In: Bone Marrow Transplantation, Bd. 51:
S474-S474
Heidenreich, S.; Ziagkos, D.; Biezen, A. van; Finke, J.; Platzbecker, U.; Niederwieser, D.; Einsele, H.; Bethge, W. A.; Schleuning, M.; Beelen, D. W.; Tischer, J.; Nagler, A.; Glass, B.; Maertens, J.; Richard, C.; Beguin, Y.; Sill, H.; Witte, T. de; Robin, M. und Kroeger, N.
(2016):
Allogeneic Stem Cell Transplantation for MDS Patients More Than 70 Years of Age: Update of a Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party (CMWP) of the EBMT.
In: Bone Marrow Transplantation, Bd. 51:
S510-S511
Haebe, S.; Totok, G.; Prevalsek, D.; Fritsch, S.; Hubmann, M.; Zöllner, A.-K.; Köhnke, T.; Schulz, C.; Ledderose, G.; Hausmann, A.; Hiddemann, W. und Tischer, J.
(2016):
HLA-haploidentical transplantation using T-cell-replete grafts and high-dose cyclophosphamide post-transplantation in the treatment of multiple myeloma: a single center experience.
In: Bone Marrow Transplantation, Bd. 51:
S356-S357
Brissot, E.; Labopin, M.; Ciceri, F.; Bornhäuser, M.; Tischer, J.; Stelljes, M.; Koc, Y.; Stuhler, G.; Fanin, R.; Ganser, A.; Glass, B.; Mohty, M. und Nagler, A.
(2016):
Comparison of haplo-identical versus unrelated allogeneic stem cell transplantation for acute myeloid leukemia with active disease: A report of 1578 patients from Acute Leukemia Working Party of EBMT.
In: Bone Marrow Transplantation, Bd. 51:
S65-S65
Dietrich, S.; Finel, H.; Martinez, C.; Tischer, J.; Blaise, D.; Chevallier, P.; Castagna, L.; Milpied, N.; Bacigalupo, A.; Corradini, P.; Mohty, M.; Sanz, M.; Hausmann, A.; Montoto, S.; Robinson, S.; Boumendil, A.; Sureda, A. und Dreger, P.
(2016):
Post-transplant cyclophosphamide-based haplo-identical transplantation as alternative to matched sibling or unrelated donor transplantation for non-Hodgkin lymphoma: a registry study by the European society for blood and marrow transplantation.
In: Leukemia, Bd. 30, Nr. 10: S. 2086-2089
Marchand, T.; Lamy, T.; Finel, H.; Arcese, W.; Choquet, S.; Finke, J.; Huynh, A.; Irrera, G.; Karakasis, D.; Konopacki, J.; Lambert, J.; Michieli, M.; Schouten, H. C.; Schroyens, W.; Sucak, G.; Tischer, J.; Vandenberghe, E. und Dreger, P.
(2016):
Hematopoietic stem cell transplantation for T-cell large granular lymphocyte leukemia: a retrospective study of the European Society for Blood and Marrow Transplantation.
In: Leukemia, Bd. 30, Nr. 5: S. 1201-1204
Heinzelmann, F.; Bethge, W.; Beelen, D. W.; Engelhard, M.; Kröger, N.; Dreger, P.; Niederwieser, D.; Finke, J.; Bunjes, D.; Tischer, J.; Kobbe, G.; Holler, E.; Bornhäuser, M.; Stelljes, M.; Baurmann, H.; Müller, A.; Haubitz, I.; Schrezenmeier, H.; Müller, C. und Ottinger, H.
(2016):
Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas.
In: Bone Marrow Transplantation, Bd. 51, Nr. 5: S. 654-662
Jedlickova, Z.; Schmid, C.; Koenecke, C.; Hertenstein, B.; Baurmann, H.; Schwerdtfeger, R.; Tischer, J.; Kolb, H.-J. und Schleuning, M.
(2016):
Long-term results of adjuvant donor lymphocyte transfusion in AML after allogeneic stem cell transplantation.
In: Bone Marrow Transplantation, Bd. 51, Nr. 5: S. 663-667
Vrhovac, R.; Labopin, M.; Ciceri, F.; Finke, J.; Holler, E.; Tischer, J.; Lioure, B.; Gribben, J.; Kanz, L.; Blaise, D.; Dreger, P.; Held, G.; Arnold, R.; Nagler, A. und Mohty, M.
(2016):
Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes.
In: Bone Marrow Transplantation, Bd. 51, Nr. 2: S. 186-193
Schmid, C.; Schleuning, M.; Hentrich, M.; Markl, G. E.; Gerbitz, A.; Tischer, J.; Ledderose, G.; Oruzio, D.; Hiddemann, Wolfgang und Kolb, H. J.
(2008):
High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission.
In: Bone Marrow Transplantation, Bd. 41, Nr. 8: S. 721-727